» Articles » PMID: 36118704

The Emerging Neuroprotective Roles of Exerkines in Alzheimer's Disease

Overview
Specialty Geriatrics
Date 2022 Sep 19
PMID 36118704
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the extensive knowledge of the beneficial effects of physical exercise, a sedentary lifestyle is still a predominant harm in our society. Sedentarism is one of the major modifiable risk factors for metabolic diseases such as diabetes mellitus, obesity and neurological disorders, including Alzheimer's disease (AD)-characterized by synaptic failure, amyloid protein deposition and memory loss. Physical exercise promotes neuroprotective effects through molecules released in circulation and mediates the physiological crosstalk between the periphery and the brain. This literature review summarizes the current understanding of the roles of exerkines, molecules released during physical exercise, as systemic and central factors that mediate the beneficial effects of physical exercise on cognition. We highlight the neuroprotective role of irisin-a myokine released from the proteolytic cleavage of fibronectin type III domain-containing protein 5 (FNDC5) transmembrane protein. Lastly, we review evidence pointing to physical exercise as a potential preventative and interventional strategy against cognitive decline in AD.

Citing Articles

BDNF-induced BDNF release: A virtuous loop for the cardioprotective effects of exercise in post-ischemic heart failure.

Maroofi A, Safari F, Abbasi A Int J Cardiol Heart Vasc. 2025; 56:101623.

PMID: 39927379 PMC: 11804723. DOI: 10.1016/j.ijcha.2025.101623.


Plasma Proteomic Signatures of Physical Activity Provide Insights into Biological Impacts of Physical Activity and its Protective Role Against Dementia.

Arani G, Arora A, Yang S, Wu J, Kraszewski J, Martins A medRxiv. 2025; .

PMID: 39867359 PMC: 11759254. DOI: 10.1101/2025.01.16.25320290.


Impact of Physical Activity on Cellular Metabolism Across Both Neurodegenerative and General Neurological Conditions: A Narrative Review.

Clemente-Suarez V, Rubio-Zarapuz A, Belinchon-deMiguel P, Beltran-Velasco A, Martin-Rodriguez A, Tornero-Aguilera J Cells. 2024; 13(23).

PMID: 39682689 PMC: 11640500. DOI: 10.3390/cells13231940.


Exercise, Neuroprotective Exerkines, and Parkinson's Disease: A Narrative Review.

Mitchell A, Bliss R, Church F Biomolecules. 2024; 14(10).

PMID: 39456173 PMC: 11506540. DOI: 10.3390/biom14101241.


'Exerkines': A Comprehensive Term for the Factors Produced in Response to Exercise.

Novelli G, Calcaterra G, Casciani F, Pecorelli S, Mehta J Biomedicines. 2024; 12(9).

PMID: 39335489 PMC: 11429193. DOI: 10.3390/biomedicines12091975.


References
1.
. 2020 Alzheimer's disease facts and figures. Alzheimers Dement. 2020; . DOI: 10.1002/alz.12068. View

2.
Carey A, Steinberg G, Macaulay S, Thomas W, Holmes A, Ramm G . Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes. 2006; 55(10):2688-97. DOI: 10.2337/db05-1404. View

3.
Wang Y, Tian M, Tan J, Pei X, Lu C, Xin Y . Irisin ameliorates neuroinflammation and neuronal apoptosis through integrin αVβ5/AMPK signaling pathway after intracerebral hemorrhage in mice. J Neuroinflammation. 2022; 19(1):82. PMC: 8988353. DOI: 10.1186/s12974-022-02438-6. View

4.
Chow L, Gerszten R, Taylor J, Pedersen B, van Praag H, Trappe S . Exerkines in health, resilience and disease. Nat Rev Endocrinol. 2022; 18(5):273-289. PMC: 9554896. DOI: 10.1038/s41574-022-00641-2. View

5.
Hook V, Kindy M, Hook G . Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. J Biol Chem. 2008; 283(12):7745-53. DOI: 10.1074/jbc.M708362200. View